" /> Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 - CISMeF





Preferred Label : Neoantigen-based Therapeutic Cancer Vaccine GRT-C903;

NCIt synonyms : Priming Vaccine GRT-C903; Shared Neoantigen Priming Cancer Vaccine GRT-C903; Shared Neoantigen Cancer Vaccine Prime GRT-C903; Priming Cancer Vaccine GRT-C903;

NCIt definition : A cancer priming vaccine consisting of tumor-specific shared neoantigens, which are immunogenic and unique across a subset of patients, with potential immunostimulating and antineoplastic activities. Upon administration of neoantigen-based therapeutic cancer vaccine GRT-C903, followed by the boosting vaccine GRT-R904, the peptides stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against the shared neoantigens expressed on tumor cells, which results in tumor cell lysis.;

Molecule name : GRT-C903; GRT C903;

NCI Metathesaurus CUI : CL978704;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.